FDA approves opioid overdose antidote Zimhi

FDA approves opioid overdose antidote Zimhi

The FDA has approved Zimhi, a high-dose naloxone product that is administered through a prefilled syringe to counteract potentially fatal opioid overdoses, the agency and the drug’s manufacturer announced.The approval comes amid CDC data that indicate 70.6% of the 70,630 drug overdose deaths in the United States in 2019 involved opioids. According to provisional data from the CDC, more than 99,000 Americans are estimated to have died from drug overdoses during the 12-month period that ended in March 2021.“I am pleased to see this much-needed high-dose naloxone product will becomeRead More

Share on facebook
Share on twitter
Share on linkedin